한글목차

펩톤 시장은 2023년에 1억 4,950만 달러로 평가되었고, 2024-2035년간 4.2%의 연평균 복합 성장률(CAGR)을 나타내고, 2035년에는 2억 4,090만 달러에 달할 것으로 예상됩니다.

펩톤은 효소와 산을 사용하여 동물, 식물 및 미생물의 단백질 공급원을 부분적으로 가수분해하여 얻은 수용성 단백질 유도체입니다. 실험실과 산업에서 박테리아, 곰팡이 및 기타 미생물의 배양에 널리 사용됩니다. 제약 연구, 진단 및 발효 과정에서 중요한 역할을 하며 항생제, 효소 및 기타 생물학적 제제 생산에 기여합니다.

세계 펩톤 시장은 제약, 학술 및 헬스케어 분야의 미생물학 기반 연구 증가와 백신, 항생제 및 프로바이오틱스 개발 노력 증가로 인해 괄목할 만한 성장세를 보이고 있습니다. 또한, 생명공학 및 제약 산업의 확대도 시장 성장에 크게 기여하고 있습니다. 또한, 감염성 질환의 확산이 증가함에 따라 세계적으로 진단 실험실에 대한 투자가 증가하고 있으며, 이는 펩톤 소비의 원동력이 되고 있습니다.

국립병원감염병실태조사(2021년)에 따르면, 감염 및 기생충 질환으로 인한 응급실 내원 환자 수는 미국에서만 380만 명에 달하는 것으로 기록되어 있습니다. 이 중 입원 환자 수는 482,000명에 달할 것으로 추정됩니다. 이는 펩톤의 긴급한 필요성을 강조하고 있습니다. 또한, 백신 제조에 펩톤의 사용 증가는 세계 시장의 주요 동력이 되고 있습니다. 이는 펩톤이 백신 생산에 사용되는 박테리아 및 바이러스와 같은 미생물을 배양하기 위한 증식 배지의 주요 영양 공급원 역할을 하기 때문입니다. 이러한 영양이 풍부한 단백질 가수분해물은 백신 제조 과정에서 미생물과 세포의 최적 증식에 필요한 필수 아미노산, 펩타이드, 비타민, 미네랄을 제공합니다. 세계 최대 오픈 액세스 연구 출판사인 Taylor &Francis가 2021년 발표한 조사에 따르면, 정기적인 백신 접종으로 매년 약 200만-300만 명의 생명을 구할 수 있는 것으로 나타났습니다. 펩톤은 식음료, 유제품, 건강보조식품을 생산하기 위한 발효 공정에 사용되기 때문에 식음료 산업에서 펩톤의 사용 증가는 향후 시장 성장을 가속할 것으로 보입니다.

그러나 효소 및 산에 의한 가수분해와 같은 복잡한 공정이 수반되는 펩톤 생산과 관련된 높은 비용이 시장 성장을 저해하고 있습니다. 또한, 합성 배지 및 화학적으로 정의된 배지의 발전은 펩톤을 대체할 수 있는 대안을 제공하고 있으며, 특히 단클론 항체 생산을 위한 세포 배양과 같이 정밀성과 재현성이 요구되는 응용 분야에서 시장 성장을 저해하고 있습니다. 반대로, 지속 가능한 바이오 제품에 대한 세계의 관심은 펩톤을 발효 영양소로서 채택을 촉진하고 있으며, 이는 시장 성장에 유리한 기회를 제공할 것으로 예상됩니다. 또한, 동물성 펩톤에 대한 우려와 제약 및 식품 응용 분야에서 비건 및 동물성 대체품으로의 전환은 식물성 또는 미생물 유래 펩톤에 대한 새로운 길을 열어주고 있습니다.

세계 펩톤 시장은 펩톤공급원, 용도, 최종 사용자, 지역으로 구분됩니다. 펩톤공급원별로 시장은 동물성 펩톤, 식물성 펩톤, 미생물 펩톤, 혼합 펩톤으로 나뉩니다. 최종 사용자별로는 제약 및 바이오 산업, 연구기관, 식음료 산업, 기타로 나뉩니다. 용도별로는 세포 배양, 발효, 식음료, 기타로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분석됩니다.

주요 조사 결과

• 펩톤공급원 기준으로는 동물성 펩톤 부문이 2023년 시장 점유율을 독점했습니다.
• 최종 사용자별로는 제약 및 바이오 산업 부문이 2023년 주요 주주로 2024년부터 2035년까지 가장 높은 CAGR로 성장할 것으로 예상됩니다.
• 용도별로는 세포 배양 분야가 2023년 가장 큰 점유율을 차지하며 예측 기간 동안 가장 높은 CAGR을 보일 것으로 예상됩니다.
• 지역별로는 북미가 2023년 펩톤 시장에서 가장 큰 주주로 나타났습니다.

경쟁사 분석

이해관계자를 위한 주요 이점

• 이 보고서는 2019년부터 2035년까지 펩톤 시장 분석 시장 부문, 현재 동향, 추정 및 동향 분석에 대한 정량적 분석을 제공하여 우세한 펩톤 시장 기회를 식별합니다.
• 시장 성장 촉진요인, 시장 성장 억제요인, 시장 기회와 관련된 정보와 함께 시장 조사를 제공합니다.
• Porter의 다섯 가지 힘 분석은 이해 관계자가 이익 중심의 비즈니스 결정을 내리고 공급업체와 공급업체의 네트워크를 강화할 수 있도록 구매자와 공급업체의 잠재력을 강조합니다.
• 펩톤 시장의 세분화를 자세히 분석하면 시장 기회를 파악할 수 있습니다.
• 각 지역의 주요 국가는 세계 시장에 대한 수익 기여도에 따라 매핑되어 있습니다.
• 시장 기업의 포지셔닝은 벤치마킹을 용이하게 하고 시장 기업의 현재 위치를 명확하게 이해할 수 있습니다.
• 이 보고서에는 지역별 및 세계 펩톤 시장 동향, 주요 기업, 시장 부문, 응용 분야 및 시장 성장 전략에 대한 분석이 포함되어 있습니다.

본 보고서에서 가능한 보고서 커스터마이징(추가 비용 및 일정이 있습니다.)

• 국가, 지역 및 세계 수준의 환자/역학 데이터
• 규제 가이드라인
• 고객의 관심사에 따른 추가 기업 프로파일
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
• 기업 프로파일 확장 목록
• 과거 시장 데이터
• SWOT 분석

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

• 시장 정의와 범위
• 주요 조사 결과
  • 영향요인
  • 주요 투자 기회
• Porter의 Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 펩톤 시장 : 공급원별

• 개요
• 동물성 펩톤
• 식물 펩톤
• 미생물 펩톤
• 혼합 펩톤

제5장 펩톤 시장 : 최종사용자별

• 개요
• 제약 및 바이오테크놀러지 산업
• 연구기관
• 식품 및 음료 산업
• 기타

제6장 펩톤 시장 : 용도별

• 개요
• 세포배양
• 발효
• 식품 및 음료
• 기타

제7장 펩톤 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 일본
  • 중국
  • 호주
  • 인도
  • 한국
  • 기타
• 라틴아메리카/중동 및 아프리카
  • 브라질
  • 사우디아라비아
  • 남아프리카공화국
  • 기타

제8장 경쟁 구도

• 서론
• 주요 성공 전략
• 주요 10개사의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2019년)

제9장 기업 개요

• Thermo Fisher Scienctific
• Solabia Group
• Kerry Group plc
• Becton, Dickinson and Company
• HiMedia Laboratories
• Liofilchem S.r.l
• Neogen Corporation
• Merck KGaA
• Titan Biotech Ltd.
• Nu-Tek BioSciences

영문목차

The peptone market was valued at $149.5 million in 2023 and is estimated to reach $240.9 million by 2035, exhibiting a CAGR of 4.2% from 2024 to 2035.

Peptone is a water-soluble protein derivative obtained through the partial hydrolysis of animal, plant, or microbial protein sources using enzymes or acids. They are widely used in laboratories and industries for cultivating bacteria, fungi, and other microorganisms. They play a crucial role in pharmaceutical research, diagnostics, and fermentation processes, contributing to the production of antibiotics, enzymes, and other biologics.

The global peptone market is witnessing notable growth due to factors such as increase in microbiology-based research in pharmaceutical, academic, and healthcare sectors and rise in efforts to develop vaccines, antibiotics, and probiotics. Furthermore, expansion of biotechnology and pharmaceutical industries significantly contributes toward the market growth. Moreover, alarming rise in prevalence of infectious diseases has resulted in increased investment in diagnostic labs globally, which, in turn, drives the consumption of peptones.

According to the prevalence of infectious diseases National Hospital Ambulatory Medical Care Survey: 2021, the number of emergency department visits due to infectious and parasitic diseases was recorded to be 3.8 million in the U.S. alone. Among these, hospital admissions were estimated to reach 482,000. This emphasizes the urgent need for peptone. In addition, increase in use of peptones in vaccine productions acts as a key driving force of the global market. This is attributed to the fact that peptones serves as the primary nutrient source in the growth media for culturing microorganisms, such as bacteria or viruses, that are used to produce vaccines. These nutrient-rich protein hydrolysates provide essential amino acids, peptides, vitamins, and minerals necessary for optimal microbial or cell growth during vaccine manufacturing. A 2021 study published by Taylor & Francis-one of the world's largest publishers of open access research revealed that approximately 2-3 million lives are saved every year due to routine vaccination. Rise in application of peptones in the food & beverages industry future fuels the market growth, as they are used in the fermentation processes for the production of beverages, dairy products, and dietary supplements.

However, high cost associated with manufacturing of peptones, which involves complex processes such as enzymatic or acid hydrolysis, restrains the market growth. In addition, advances in synthetic and chemically defined media are offering alternatives to peptones, particularly in applications requiring precision and reproducibility, such as cell culture for monoclonal antibody production, thereby hampering the market growth. On the contrary, the global focus on sustainable bio-based products supports the adoption of peptones as fermentation nutrients, which is expected to offer lucrative opportunities for the market growth. Moreover, concerns over animal-derived peptones and a shift toward vegan and animal-free alternatives in pharmaceuticals and food applications have opened new avenues for plant-based or microbial peptones.

The global peptone market is segmented into source of peptone, application, end user, and region. By source of peptone, the market is divided into animal peptone, plant peptone, microbial peptone, and mixed peptone. On the basis of end user, it is segregated into pharmaceutical & biotech industry, research institutions, food & beverage industry, and others. Depending on application, it is categorized into cell culture, fermentation, food & beverages, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

• On the basis of source of peptone, the animal peptone segment dominated the market share in 2023.
• Depending on end user, the pharmaceutical & biotech industry segment was the major shareholder in 2023, and is expected to grow at the highest CAGR from 2024 to 2035.
• By application, the cell culture segment garnered the largest share in 2023, and is anticipated to exhibit the highest CAGR during the forecast period
• Region wise, North America was the largest shareholder in the peptone market in 2023.

Competitive Analysis

The key players that operate in the global peptone market are Thermo Fisher Scientific Inc., Solabia Group, Kerry Inc, Nu-Tek Biosciences, Becton Dickinson and Company, Himedia Laboratories, Liofilchem S.R.L, Neogen Corporation, Merck KGaA, and Titan Biotech Ltd. These players have adopted acquisition, agreement, collaboration, joint venture, partnership, and product launch as their key developmental strategies to sustain the intense competition and gain a strong foothold in the global market.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the peptone market analysis from 2019 to 2035 to identify the prevailing peptone market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the peptone market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global peptone market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Patient/epidemiology data at country, region, global level
• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• SWOT Analysis

Key Market Segments

By Source of Peptone

• Animal Peptone
• Plant Peptone
• Microbial Peptone
• Mixed Peptone

By End User

• Pharmaceutical and Biotech Industry
• Research Institutions
• Food and Beverage Industry
• Others

By Application

• Cell Culture
• Fermentation
• Food and Beverages
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Kerry Group plc
• Becton, Dickinson and Company
• HiMedia Laboratories
• Neogen Corporation
• Merck KGaA
• Solabia Group
• Titan Biotech Ltd.
• Thermo Fisher Scienctific
• Liofilchem S.r.l
• Nu-Tek BioSciences

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
• 3.4. Market dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: PEPTONE MARKET, BY SOURCE OF PEPTONE

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Animal Peptone
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Plant Peptone
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. Microbial Peptone
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country
• 4.5. Mixed Peptone
  • 4.5.1. Key market trends, growth factors and opportunities
  • 4.5.2. Market size and forecast, by region
  • 4.5.3. Market share analysis by country

CHAPTER 5: PEPTONE MARKET, BY END USER

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Pharmaceutical and Biotech Industry
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Research Institutions
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Food and Beverage Industry
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
• 5.5. Others
  • 5.5.1. Key market trends, growth factors and opportunities
  • 5.5.2. Market size and forecast, by region
  • 5.5.3. Market share analysis by country

CHAPTER 6: PEPTONE MARKET, BY APPLICATION

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Cell Culture
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Fermentation
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Food and Beverages
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country
• 6.5. Others
  • 6.5.1. Key market trends, growth factors and opportunities
  • 6.5.2. Market size and forecast, by region
  • 6.5.3. Market share analysis by country

CHAPTER 7: PEPTONE MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by Source of Peptone
  • 7.2.3. Market size and forecast, by End User
  • 7.2.4. Market size and forecast, by Application
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Market size and forecast, by Source of Peptone
    • 7.2.5.1.2. Market size and forecast, by End User
    • 7.2.5.1.3. Market size and forecast, by Application
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Market size and forecast, by Source of Peptone
    • 7.2.5.2.2. Market size and forecast, by End User
    • 7.2.5.2.3. Market size and forecast, by Application
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Market size and forecast, by Source of Peptone
    • 7.2.5.3.2. Market size and forecast, by End User
    • 7.2.5.3.3. Market size and forecast, by Application
• 7.3. Europe
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by Source of Peptone
  • 7.3.3. Market size and forecast, by End User
  • 7.3.4. Market size and forecast, by Application
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Market size and forecast, by Source of Peptone
    • 7.3.5.1.2. Market size and forecast, by End User
    • 7.3.5.1.3. Market size and forecast, by Application
    • 7.3.5.2. France
    • 7.3.5.2.1. Market size and forecast, by Source of Peptone
    • 7.3.5.2.2. Market size and forecast, by End User
    • 7.3.5.2.3. Market size and forecast, by Application
    • 7.3.5.3. UK
    • 7.3.5.3.1. Market size and forecast, by Source of Peptone
    • 7.3.5.3.2. Market size and forecast, by End User
    • 7.3.5.3.3. Market size and forecast, by Application
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Market size and forecast, by Source of Peptone
    • 7.3.5.4.2. Market size and forecast, by End User
    • 7.3.5.4.3. Market size and forecast, by Application
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Market size and forecast, by Source of Peptone
    • 7.3.5.5.2. Market size and forecast, by End User
    • 7.3.5.5.3. Market size and forecast, by Application
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Market size and forecast, by Source of Peptone
    • 7.3.5.6.2. Market size and forecast, by End User
    • 7.3.5.6.3. Market size and forecast, by Application
• 7.4. Asia-Pacific
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by Source of Peptone
  • 7.4.3. Market size and forecast, by End User
  • 7.4.4. Market size and forecast, by Application
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Market size and forecast, by Source of Peptone
    • 7.4.5.1.2. Market size and forecast, by End User
    • 7.4.5.1.3. Market size and forecast, by Application
    • 7.4.5.2. China
    • 7.4.5.2.1. Market size and forecast, by Source of Peptone
    • 7.4.5.2.2. Market size and forecast, by End User
    • 7.4.5.2.3. Market size and forecast, by Application
    • 7.4.5.3. Australia
    • 7.4.5.3.1. Market size and forecast, by Source of Peptone
    • 7.4.5.3.2. Market size and forecast, by End User
    • 7.4.5.3.3. Market size and forecast, by Application
    • 7.4.5.4. India
    • 7.4.5.4.1. Market size and forecast, by Source of Peptone
    • 7.4.5.4.2. Market size and forecast, by End User
    • 7.4.5.4.3. Market size and forecast, by Application
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Market size and forecast, by Source of Peptone
    • 7.4.5.5.2. Market size and forecast, by End User
    • 7.4.5.5.3. Market size and forecast, by Application
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Market size and forecast, by Source of Peptone
    • 7.4.5.6.2. Market size and forecast, by End User
    • 7.4.5.6.3. Market size and forecast, by Application
• 7.5. LAMEA
  • 7.5.1. Key market trends, growth factors and opportunities
  • 7.5.2. Market size and forecast, by Source of Peptone
  • 7.5.3. Market size and forecast, by End User
  • 7.5.4. Market size and forecast, by Application
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Market size and forecast, by Source of Peptone
    • 7.5.5.1.2. Market size and forecast, by End User
    • 7.5.5.1.3. Market size and forecast, by Application
    • 7.5.5.2. Saudi Arabia
    • 7.5.5.2.1. Market size and forecast, by Source of Peptone
    • 7.5.5.2.2. Market size and forecast, by End User
    • 7.5.5.2.3. Market size and forecast, by Application
    • 7.5.5.3. South Africa
    • 7.5.5.3.1. Market size and forecast, by Source of Peptone
    • 7.5.5.3.2. Market size and forecast, by End User
    • 7.5.5.3.3. Market size and forecast, by Application
    • 7.5.5.4. Rest of LAMEA
    • 7.5.5.4.1. Market size and forecast, by Source of Peptone
    • 7.5.5.4.2. Market size and forecast, by End User
    • 7.5.5.4.3. Market size and forecast, by Application

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product mapping of top 10 player
• 8.4. Competitive dashboard
• 8.5. Competitive heatmap
• 8.6. Top player positioning, 2019

CHAPTER 9: COMPANY PROFILES

• 9.1. Thermo Fisher Scienctific
  • 9.1.1. Company overview
  • 9.1.2. Key executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
  • 9.1.6. Business performance
  • 9.1.7. Key strategic moves and developments
• 9.2. Solabia Group
  • 9.2.1. Company overview
  • 9.2.2. Key executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
  • 9.2.6. Business performance
  • 9.2.7. Key strategic moves and developments
• 9.3. Kerry Group plc
  • 9.3.1. Company overview
  • 9.3.2. Key executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
  • 9.3.6. Business performance
  • 9.3.7. Key strategic moves and developments
• 9.4. Becton, Dickinson and Company
  • 9.4.1. Company overview
  • 9.4.2. Key executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
  • 9.4.6. Business performance
  • 9.4.7. Key strategic moves and developments
• 9.5. HiMedia Laboratories
  • 9.5.1. Company overview
  • 9.5.2. Key executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
  • 9.5.6. Business performance
  • 9.5.7. Key strategic moves and developments
• 9.6. Liofilchem S.r.l
  • 9.6.1. Company overview
  • 9.6.2. Key executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
  • 9.6.6. Business performance
  • 9.6.7. Key strategic moves and developments
• 9.7. Neogen Corporation
  • 9.7.1. Company overview
  • 9.7.2. Key executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
  • 9.7.6. Business performance
  • 9.7.7. Key strategic moves and developments
• 9.8. Merck KGaA
  • 9.8.1. Company overview
  • 9.8.2. Key executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
  • 9.8.6. Business performance
  • 9.8.7. Key strategic moves and developments
• 9.9. Titan Biotech Ltd.
  • 9.9.1. Company overview
  • 9.9.2. Key executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
  • 9.9.6. Business performance
  • 9.9.7. Key strategic moves and developments
• 9.10. Nu-Tek BioSciences
  • 9.10.1. Company overview
  • 9.10.2. Key executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio
  • 9.10.6. Business performance
  • 9.10.7. Key strategic moves and developments